Reply to "Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?"

Affiliations

• ¹ The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
• ² Hematology Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy.
• ³ Department of Pediatric and Adolescent Oncology, National Institute of Health and Medical Research Unit 1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
• ⁴ Pathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
• ⁵ Ruth Rappaport Children's Hospital, Rambam Medical Center, Joan and Sanford Weill Pediatric Hematology Oncology and Bone Marrow Transplantation Division, Haifa, Israel.
• ⁶ Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
• ⁷ Department of Pediatric Surgery, Royal Manchester Children's Hospital, Manchester, UK.
• ⁸ Hôpital Universitaire des Enfants Reine Fabiola, l'Université Libre de Bruxelles, Brussels, Belgium.
• ⁹ Pediatric Oncology Department, National Cancer Institute, Rio de Janeiro, Brazil.
• ¹⁰ Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
• ¹¹ Center for Rare Disorders, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
• ¹² Department of Pediatric Oncology and Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
• ¹³ Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
• ¹⁴ Pediatric Oncology Department University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic.
• ¹⁵ SIREDO Oncology Center, Institut Curie, Paris Sciences and Letters University, Paris, France.
• ¹⁶ Department of Radiotherapy, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
• ¹⁷ Children's Hospital for Wales, Cardiff, UK.